Australia’s top brokers have been busy adjusting their estimates and recommendations again, leading to the release of a large number of broker notes this week.
Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:
Aristocrat Leisure Limited (ASX: ALL)
According to a note out of UBS, its analysts have retained their buy rating and lifted the price target on this gaming technology company’s shares to $34.25. The broker notes that the vast majority of casinos in the United States are now open. It feels this bodes well for Aristocrat’s overall growth in the near term. Especially given its growing digital business, which has been doing a lot of the heavy lifting lately. I agree with UBS and would be a buyer of its shares right now.
Cochlear Limited (ASX: COH)
Analysts at Morgan Stanley have retained their overweight rating and $229.00 price target on this hearing solutions company’s shares. According to the note, the broker believes the company is winning market share and will continue to do so thanks to its new Kanso 2 product. In addition to this, it is a fan of Cochlear’s Remote Check offering, which was approved by the FDA a few months ago. I think Morgan Stanley is spot on and feel Cochlear would be a great long term option for investors.
Sonic Healthcare Limited (ASX: SHL)
Another note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $35.00 price target on this healthcare company’s shares. The broker notes that Sonic has just won another major COVID-19 testing contract in the United States. It estimates that this could be worth upwards of US$3 billion to the company over 12 months. I agree with Morgan Stanley and feel Sonic could be worth a closer look.
Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- 4 ASX shares I’m looking to buy today
- 2 quality ASX shares to buy now to get rich later
- Where I would invest my BHP dividends in September
- Why a recession shouldn’t matter for the ASX share market
- 3 ASX blue-chip shares I would buy at today’s prices
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and Sonic Healthcare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Brokers name 3 ASX shares to buy right now appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/3gWR6Pe
Leave a Reply